Skip to main content
. 2020 Jun 27;15(4):312–320. doi: 10.1016/j.jtumed.2020.04.007

Table 4.

Effect of UDCA on the concentration of inflammatory mediators in liver tissue in the prevention and treatment of cholestasis-induced by LPS in rats.

Groups TNF-α
Mean ± SD
IL-1α
Mean ± SD
IL-4
Mean ± SD
Control group (n=12) 37.40 ± 2.47b,c 714.60 ± 73.32b 625.60 ± 124.25
UDCA group (n=12) 39.60 ± 7.42b 700.90 ± 54.25b 600.80 ± 100.57
LPS group (n=12) 75.63 ± 3.72a 898.50 ± 63.56 804.25 ± 61.01
Treatment group (n=12) 62.83 ± 9.20a 851.33 ± 130.38 851.67 ± 51.00
Prevention group (n=12) 55.38 ± 13.15b 832.63 ± 80.01 749.63 ± 89.55c

Data are presented as mean ± S.D.

a

Significant change compared to control at P < 0.05.

b

Significant change compared to LPS group at P < 0.05.

c

Significant change compared to treatment group at P < 0.05.

HHS Vulnerability Disclosure